Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH

We investigated specific humoral and T-cell responses in people living with HIV (PLWH) before (T0), after two (T1) and after six months (T2) from the third dose of the BNT162b2 vaccine. Healthy donors (HD) were enrolled. The specific humoral response was present in most PLWH already after the second...

Descripción completa

Detalles Bibliográficos
Autores principales: Tortellini, Eeva, Zingaropoli, Maria Antonella, Mancarella, Giulia, Marocco, Raffaella, Carraro, Anna, Jamhour, Meriem, Barbato, Christian, Guardiani, Mariasilvia, Dominelli, Federica, Pasculli, Patrizia, Napoli, Anna, Gaeta, Aurelia, Mengoni, Fabio, Zuccalà, Paola, Belvisi, Valeria, Kertusha, Blerta, Parente, Alberico, Del Borgo, Cosmo, Vullo, Vincenzo, Ciardi, Maria Rosa, Mastroianni, Claudio Maria, Lichtner, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741180/
https://www.ncbi.nlm.nih.gov/pubmed/36499317
http://dx.doi.org/10.3390/ijms232314988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741180/
https://www.ncbi.nlm.nih.gov/pubmed/36499317
http://dx.doi.org/10.3390/ijms232314988

Ejemplares similares